Questions, Feedback & Help
Send us an email and we'll get back to you ASAP. Or you can read our Frequently Asked Questions.
  • page settings
  • hide sidebar
  • show empty fields
  • layout
  • (too narrow)
  • open all
  • close all
Resources » Paper

Ma L et al. (2017) Eur J Pharmacol "Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases."

  • History

  • Referenced

  • Tree Display

  • My Favorites

  • My Library

  • Comments on Ma L et al. (2017) Eur J Pharmacol "Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases." (0)

  • Overview

    PMID:
    29208474
    DOI:
    10.1016/j.ejphar.2017.11.051
    Status:
    Publication type:
    Review
    WormBase ID:
    WBPaper00053432

    Ma L, Zhao Y, Chen Y, Cheng B, Peng A, & Huang K (2017). Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases. Eur J Pharmacol. doi:10.1016/j.ejphar.2017.11.051

    Over the past decades, C. elegans has been widely used as a model system because of its small size, transparent body, short generation time and lifespan (~3 days and 3 weeks, respectively), completely sequenced genome and tractability to genetic manipulation. Protein misfolding and aggregation are key pathological features in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease and Amyotrophic lateral sclerosis. Animal models, including Caenorhabditis elegans (C. elegans), have been extensively used to discover and validate new drugs against neurodegenerative diseases. The well-defined and genetically tractable nervous system of C. elegans offers an effective model to explore basic mechanistic pathways of neurodegenerative diseases. Recent progress in high-throughput drug screening also provides a powerful approach for identifying chemical modulators of biological processes. Here, we summarize the latest progress of using C. elegans as a model system for target identification and drug screening in neurodegenerative diseases.


    Tip: Seeing your name marked red? Please help us identify you.